Posted On: 04/15/2015 8:54:25 AM
Post# of 63843
$CASM Pr at recovery support $1.37
called 11/ 2 /13 $1.48
website
7:03 am CAS Medical announces
FDA approval for FORE-SIGHT ELITE
in pediatric and neonatal patients
Shares Outstanding: 19.30M
Float: 12.44M
% Held by Insiders: 9.46%
% Held by Institutions: 43.90%
Shares Short (as of Mar 31, 2015): 38.84K
Short Ratio (as of Mar 31, 2015): 0.50
Short % of Float (as of Mar 31, 2015): 0.50%
Shares Short (prior month): 35.04K
Headlines
called 11/ 2 /13 $1.48
website
7:03 am CAS Medical announces
FDA approval for FORE-SIGHT ELITE
in pediatric and neonatal patients
Shares Outstanding: 19.30M
Float: 12.44M
% Held by Insiders: 9.46%
% Held by Institutions: 43.90%
Shares Short (as of Mar 31, 2015): 38.84K
Short Ratio (as of Mar 31, 2015): 0.50
Short % of Float (as of Mar 31, 2015): 0.50%
Shares Short (prior month): 35.04K
Headlines
(0)
(0)
